Corporate Overview May 2021 2 Forward Looking Statements Some of the statements in this presentation constitute "forward looking statements" under the Private Securities Litigation Reform Act of 1995, including, but not limited to, our development plans, the promise and potential impact of any of our microbiome therapeutics, the ability of our clinical trials to support approval, the timing and results of clinical studies, the timing and ultimate results of the SER- 109 safety data, the size of the market f ...